Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
108.37
-0.26 (-0.24%)
May 5, 2025, 4:00 PM EDT - Market closed
Agilent Technologies Employees
Agilent Technologies had 17,900 employees as of October 31, 2024. The number of employees decreased by 200 or -1.10% compared to the previous year.
Employees
17,900
Change (1Y)
-200
Growth (1Y)
-1.10%
Revenue / Employee
$364,972
Profits / Employee
$70,335
Market Cap
30.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 17,900 | -200 | -1.10% |
Oct 31, 2023 | 18,100 | 0 | - |
Oct 31, 2022 | 18,100 | 1,100 | 6.47% |
Oct 31, 2021 | 17,000 | 600 | 3.66% |
Oct 31, 2020 | 16,400 | 100 | 0.61% |
Oct 31, 2019 | 16,300 | 1,500 | 10.14% |
Oct 31, 2018 | 14,800 | 1,300 | 9.63% |
Oct 31, 2017 | 13,500 | 1,000 | 8.00% |
Oct 31, 2016 | 12,500 | 700 | 5.93% |
Oct 31, 2015 | 11,800 | -9,600 | -44.86% |
Oct 31, 2014 | 21,400 | 800 | 3.88% |
Oct 31, 2013 | 20,600 | 100 | 0.49% |
Oct 31, 2012 | 20,500 | 1,800 | 9.63% |
Oct 31, 2011 | 18,700 | 200 | 1.08% |
Oct 31, 2010 | 18,500 | 1,700 | 10.12% |
Oct 31, 2009 | 16,800 | -2,800 | -14.29% |
Oct 31, 2008 | 19,600 | 200 | 1.03% |
Oct 31, 2007 | 19,400 | 700 | 3.74% |
Oct 31, 2006 | 18,700 | -2,300 | -10.95% |
Oct 31, 2005 | 21,000 | -7,000 | -25.00% |
Oct 31, 2004 | 28,000 | -1,000 | -3.45% |
Oct 31, 2003 | 29,000 | -7,000 | -19.44% |
Oct 31, 2002 | 36,000 | -5,000 | -12.20% |
Oct 31, 2001 | 41,000 | -6,000 | -12.77% |
Oct 31, 2000 | 47,000 | 5,000 | 11.90% |
Oct 31, 1999 | 42,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
A News
- 4 days ago - Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research - Business Wire
- 11 days ago - City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto - Seeking Alpha
- 11 days ago - Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission - GlobeNewsWire
- 11 days ago - Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025 - Business Wire
- 18 days ago - Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma - Business Wire
- 4 weeks ago - Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today - Seeking Alpha
- 6 weeks ago - Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval - Business Wire
- 6 weeks ago - CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025 - Business Wire